Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
JAMA Network Open|November 18, 2021
Characteristics of Cost-effectiveness Studies for Oncology Drugs Approved in the United States From 2015-2020Alyson Haslam, Mark P Lythgoe, Emma Greenstreet Akman, et al.
Familial Cancer|December 1, 2017
Metachronous colorectal cancer following segmental or extended colectomy in Lynch syndrome: a systematic review and meta-analysisSalim S Malik, Mark P Lythgoe, Mark McPhail, et al.
Trends in Cancer|May 9, 2024
Lifileucel: the first cellular therapy approved for solid tumoursMax Julve, Mark P Lythgoe, James Larkin, et al.
Trends in Microbiology|September 4, 2022
Polymorphic microbes: a new emerging hallmark of cancerMark P Lythgoe, Benjamin H Mullish, Adam E Frampton, et al.
Journal of Clinical Pathology|October 19, 2023
Gene of the month: cancer testis antigen gene 1b (NY-ESO-1)Max Julve, Oliver Kennedy, Adam Enver Frampton, et al.
Trends in Microbiology|October 29, 2021
The potential of fecal microbiota transplantation in oncologyMark P Lythgoe, Rohma Ghani, Benjamin H Mullish, et al.
Drug Discovery Today|November 19, 2020
Development and economic trends in anticancer drugs licensed in the UK from 2015 to 2019Mark P Lythgoe, Jonathan Krell, Sarah Mahmoud, et al.
BMJ Oncology|January 31, 2025
As bleak as it sounds? Analysing trends in oncology clinical trial initiation in the UK from 2010 to 2022Alexander David VanHelene, Matthew J Hadfield, Dario Trapani, et al.
The Lancet Regional Health. Europe|September 23, 2024
Efficacy and safety of interim oncology treatments introduced for solid cancers during the COVID-19 pandemic in England: a retrospective evidence-based analysisMark P Lythgoe, Alica-Joana Emhardt, Huseyin Naci, et al.
Pharmacology & Therapeutics|May 3, 2016
Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the futureMark P Lythgoe, Christopher J Rhodes, Pavandeep Ghataorhe, et al.
Pageof 9